The clinical implications of telomerase activity in upper tract urothelial cancer and washings

BJU International

Volumn 86, Issue 3, 2000, Pages 213-219

  Wu, W J ^a,b   Liu, L T ^a   Huang, C N ^a   Huang, C H ^a   Chang, Lin Li ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

Author keywords

Telomerase; TRAP ELISA assay; Upper tract urothelial cancer; Urothelial washing

Indexed keywords

TELOMERASE; TUMOR MARKER;

ARTICLE; BLADDER IRRIGATION; CANCER CELL; CANCER GRADING; CANCER INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME ACTIVITY; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; KIDNEY METASTASIS; KIDNEY PELVIS CARCINOMA; PRIORITY JOURNAL; URINE CYTOLOGY; UROGENITAL TRACT TUMOR;

CARCINOMA, TRANSITIONAL CELL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; KIDNEY NEOPLASMS; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 0033867706     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2000.00830.x     Document Type: Article

References (32)

1. 1 Blackburn EH. Structure and function of the telomere. Nature (Lond) 1991; 350: 569-73
2. 2 Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989; 59: 521-9
3. 3 Rhyu MS. Telomeres, telomerase and immortality. J Natl Cancer Inst 1995; 87: 884-94
4. 4 Harley CB. Telomere loss: mitotic clock or genetic time bomb? Mutation Res 1991; 256: 271-82
5. 5 Wright WE, Shay JW. Telomere positional effects and the regulation of cellular senescence. Trends Genet 1992; 8: 193-7
6. 6 Kim NW, Piatyszek MA, Prowse KR et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-5
7. 7 Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997; 33: 787-91
8. 8 Chen CJ, Chuang YC, Lin TM, Wu HY. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well and cancers. Cancer Res 1985; 45: 5895-9
9. 9 Chen CJ, Chuang YC, You SL, Lin TM, Wu HY. A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. Br J Cancer 1986; 53: 399-405
10. 10 Markovic B. Endemic nephritis and urinary tract cancer in Yugoslavia, Bulgaria and Rumania. J Urol 1972; 107: 212-9
11. 11 Hsieh YF, Ling GC, Lu YB, Yeh MT, Chiang CP. Incidence of tumor of the renal pelvis in Taiwan. J Formosan Med Assoc 1979; 78: 749-53
12. 12 International Union Against Cancer. Urological tumors. In Hermanek P, Sobin LH, eds. TNM Classification of Malignant Tumors. 4th edn, 2nd revision. Berlin: Springer-Verlag, 1992: 135-59
13. 13 Mostofi FK, Sobin LH, Torloni H. Histological typing of urinary bladder tumors. Geneva: WHO, 1973
14. 14 Kyo S, Kunimi K, Uchibayashi T, Namiki M, Inoue M. Telomerase activity in human urothelial tumors. Am J Clin Pathol 1997; 107: 555-60
15. 15 Hoos A, Hepp HH, Kaul S, Ahlert T, Bastert G, Wallwiener D. Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer. Int J Cancer (Pred Oncol) 1998; 79: 8-12
16. 16 Tahara H, Nakanishi T, Kitamoto M et al. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 1995; 55: 2734-6
17. 17 Chadeneau C, Hay K, Hirte HW, Gallinger S, Bacchetti S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 1995; 55: 2533-6
18. 18 Hiyama E, Yokoyama T, Tatsumoto N et al. Telomerase activity in gastric cancer. Cancer Res 1995; 55: 3258-62
19. 19 Langford LA, Piatyszek MA, Xu R, Schold SC Jr, Shay JW. Telomerase activity in human brain tumors. Lancet 1995; 346: 1267-8
20. 20 Kyo S, Takakura M, Ishikawa H et al. Application of telomerase assay for the screening of cervical lesions. Cancer Res 1997; 57: 1863-7
21. 21 Stamps AC, Gusterson BA, O'Hare MT. Are tumors immortal? Eur J Cancer 1992; 28A: 1495-500
22. 22 Hiyama K, Hiyama E, Ishioka S et al. Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst 1995; 87: 895-902
23. 23 Greider CW. Telomere length regulation. Ann Rev Biochem 1996; 65: 337-65
24. 24 Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 1995; 14: 4240-8
25. 25 Lundblad V, Wright WE. Telomeres and telomerase: a simple picture becomes complex. Cell 1996; 87: 369-75
26. 26 Belair CD, Yeager TR, Lopeez PM, Reznikoff CA. Telomerase activity: a biomarker of cell proliferation, not malignant transformation. Proc Natl Acad Sci USA 1997; 94: 13677-82
27. 27 Kim NW. Clinical implications of telomerase in cancer. Eur J Cancer 1997; 33: 781-6
28. 28 Saito Y, Kosugi SI, Suda T et al. Telomerase activity and metastasis: expansion of cells having higher telomerase activity within culture lines and tumor tissues. Jpn J Cancer Res 1997; 88: 732-7
29. 29 Yoshida K, Sugino T, Tahara H et al. Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Cancer 1997; 79: 362-9
30. 30 Lin Y, Miyamoto H, Fujinami K et al. Telomerase activity in human bladder cancer. Clin Cancer Res 1996; 2: 929-32
31. 31 Su IJ, Chen WJ. High risk of transitional cell carcinoma of urinary tract in an endemic area of chronic arsenism in Taiwan. J Chinese Oncol Soc 1985; 1: 29-36
32. 32 Kinoshita H, Ogawa O, Kakehi Y et al. Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer. J Natl Cancer Inst 1997; 89: 724-30